News

The latest company news from Exploristics
16-945 Pulmonary Suite Launch_feature tile

For January 2024, Exploristics is pleased to be launching the Pulmonary Suite, a collection of robust pulmonary disease specific data models for targeted clinical trial design optimisation.

ENA Respiiratory

Exploristics is pleased to announce a new collaboration agreement with ENA Respiratory to embed smart study design using simulation-guided clinical trial design platform, KerusCloud

Aiden and Katie in action at the PSI Conference 2023

In June, an Exploristics team comprised of Aiden Flynn, Kim Hacquoil, Sam Matthews, Andrew Mills and Katie Taiyari were delighted to attend the annual PSI Conference 2023 in Hammersmith.

KerusCloud2023 launch

We are pleased to announce the global launch of the KerusCloud Spring 2023 release, Exploristics’ ground-breaking clinical trial design platform.

Belfast-Business-Promise-260-200

Exploristics is delighted to be participating in Belfast City Council’s new inclusive growth initiative, the Belfast Business Promise.

Innovate UK logo

Exploristics has completed an Innovate UK award supporting further R&D for KerusCloud.

The Effective Statistician

Exploristics are pleased to be participating in the first Effective Statistician Conference which will take place on April 25th, 2023

KerusCloud Spring 2022 Release

We are pleased to announce the global launch of the KerusCloud Spring 2022 release, Exploristics’ ground-breaking clinical trial design platform.

Exploristics awarded Silver Diversity Charter Mark

We are proud to announce that Exploristics has attained the Silver Diversity Charter Mark.

clarivate

Integration of Clarivate Cortellis data with cloud-based simulation platform, KerusCloud, for smarter, more efficient study design 

Collaboration with the Francis Crick Institute and UCL on the COVASE trial

Exploristics is delighted that its work on the COVASE trial with the Crick, UCH and Target to Treatment has won the 2021 Sir David Cooksey prize

renovion

Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform KerusCloud

innovate-uk

Innovate UK grants Smart Award to expand KerusCloud.

Susan-Clement-Davies

Exploristics is delighted to welcome Susan Clement-Davies to the Board as a Non-Executive Director. Susan is an experienced life sciences financier

Aiden Flynn

We are delighted to announce that Exploristics’ CEO, Dr Aiden Flynn, has been appointed Commercial Director on the Board of Directors at PSI.

Istesso

Exploristics is pleased to announce a new collaboration agreement with Istesso to embed study simulation using innovative software platform KerusCloud.

KC2021-news

We are pleased to announce the global launch of the KerusCloud Spring 2021 release, Exploristics’ ground-breaking clinical trial design platform.

WISE

Exploristics have joined the WISE Campaign, and are delighted to be part of the journey promoting STEM, equality, diversity and inclusion.

galapagos

Exploristics signs collaboration agreement with Galapagos to embed study simulation into clinical development with innovative software platform KerusCloud.

Wise

We’re delighted to have been awarded membership of the NIWISE hub.

ukri

Exploristics joins the Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT).

exploristics platinum innovator award

Exploristics has been recognised as a Platinum Level Innovator by Innovate NI.

exploristics spencer health solutions

Exploristics’ CEO discusses how data simulation studies can reduce the risk and costs of clinical trials.

Collaboration with the Francis Crick Institute and UCL on the COVASE trial

Exploristics is pleased to announce its involvement with the COVASE trial evaluating cystic fibrosis drug, Dornase alfa, as a treatment for COVID-19.

UK BioIndustry Association

Exploristics is pleased to have become a member of the UK BioIndustry Association.

exploristics KerusCloud update launch

We are hosting an initial series of webinars following the global launch of KerusCloud 2.

exploristics KerusCloud update launch

We are pleased to announce the global launch of the next generation of the ground-breaking KerusCloud 2.

exploristics diversity mark 1

Exploristics receives Bronze Diversity Charter Mark

exploristics avicenna alliance

Exploristics is pleased announce that we have joined the Avicenna Alliance.

innovate-uk

Exploristics has won a prestigious Innovate UK Smart award for £340K.

exploristics pharma industry awards

Exploristics nominated for the Innovation of the Year award at the Irish Pharma Industry Awards 2019.

exploristics diversity mark

Exploristics has been awarded the Bronze Diversity Mark Charter Mark.

exploristics celebrate 10 years business

Exploristics is celebrating its ten year anniversary!

Chris Molloy exploristics new non-executive

Two new announcements this week from Exploristics.

16-945 Pulmonary Suite Launch_feature tile

For January 2024, Exploristics is pleased to be launching the Pulmonary Suite, a collection of robust pulmonary disease specific data models for targeted clinical trial design optimisation.

ENA Respiiratory

Exploristics is pleased to announce a new collaboration agreement with ENA Respiratory to embed smart study design using simulation-guided clinical trial design platform, KerusCloud

Aiden and Katie in action at the PSI Conference 2023

In June, an Exploristics team comprised of Aiden Flynn, Kim Hacquoil, Sam Matthews, Andrew Mills and Katie Taiyari were delighted to attend the annual PSI Conference 2023 in Hammersmith.

KerusCloud2023 launch

We are pleased to announce the global launch of the KerusCloud Spring 2023 release, Exploristics’ ground-breaking clinical trial design platform.

Belfast-Business-Promise-260-200

Exploristics is delighted to be participating in Belfast City Council’s new inclusive growth initiative, the Belfast Business Promise.

Innovate UK logo

Exploristics has completed an Innovate UK award supporting further R&D for KerusCloud.

The Effective Statistician

Exploristics are pleased to be participating in the first Effective Statistician Conference which will take place on April 25th, 2023

KerusCloud Spring 2022 Release

We are pleased to announce the global launch of the KerusCloud Spring 2022 release, Exploristics’ ground-breaking clinical trial design platform.

Exploristics awarded Silver Diversity Charter Mark

We are proud to announce that Exploristics has attained the Silver Diversity Charter Mark.

clarivate

Integration of Clarivate Cortellis data with cloud-based simulation platform, KerusCloud, for smarter, more efficient study design 

Collaboration with the Francis Crick Institute and UCL on the COVASE trial

Exploristics is delighted that its work on the COVASE trial with the Crick, UCH and Target to Treatment has won the 2021 Sir David Cooksey prize

renovion

Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform KerusCloud

innovate-uk

Innovate UK grants Smart Award to expand KerusCloud.

Susan-Clement-Davies

Exploristics is delighted to welcome Susan Clement-Davies to the Board as a Non-Executive Director. Susan is an experienced life sciences financier

Aiden Flynn

We are delighted to announce that Exploristics’ CEO, Dr Aiden Flynn, has been appointed Commercial Director on the Board of Directors at PSI.

Istesso

Exploristics is pleased to announce a new collaboration agreement with Istesso to embed study simulation using innovative software platform KerusCloud.

KC2021-news

We are pleased to announce the global launch of the KerusCloud Spring 2021 release, Exploristics’ ground-breaking clinical trial design platform.

WISE

Exploristics have joined the WISE Campaign, and are delighted to be part of the journey promoting STEM, equality, diversity and inclusion.

galapagos

Exploristics signs collaboration agreement with Galapagos to embed study simulation into clinical development with innovative software platform KerusCloud.

Wise

We’re delighted to have been awarded membership of the NIWISE hub.

ukri

Exploristics joins the Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT).

exploristics platinum innovator award

Exploristics has been recognised as a Platinum Level Innovator by Innovate NI.

exploristics spencer health solutions

Exploristics’ CEO discusses how data simulation studies can reduce the risk and costs of clinical trials.

Collaboration with the Francis Crick Institute and UCL on the COVASE trial

Exploristics is pleased to announce its involvement with the COVASE trial evaluating cystic fibrosis drug, Dornase alfa, as a treatment for COVID-19.

UK BioIndustry Association

Exploristics is pleased to have become a member of the UK BioIndustry Association.

exploristics KerusCloud update launch

We are hosting an initial series of webinars following the global launch of KerusCloud 2.

exploristics KerusCloud update launch

We are pleased to announce the global launch of the next generation of the ground-breaking KerusCloud 2.

exploristics diversity mark 1

Exploristics receives Bronze Diversity Charter Mark

exploristics avicenna alliance

Exploristics is pleased announce that we have joined the Avicenna Alliance.

innovate-uk

Exploristics has won a prestigious Innovate UK Smart award for £340K.

exploristics pharma industry awards

Exploristics nominated for the Innovation of the Year award at the Irish Pharma Industry Awards 2019.

exploristics diversity mark

Exploristics has been awarded the Bronze Diversity Mark Charter Mark.

exploristics celebrate 10 years business

Exploristics is celebrating its ten year anniversary!

Chris Molloy exploristics new non-executive

Two new announcements this week from Exploristics.

For January 2024, Exploristics is pleased to be launching the Pulmonary Suite, a collection of robust pulmonary disease specific data models for targeted clinical trial design optimisation.

ENA Respiiratory

Exploristics is pleased to announce a new collaboration agreement with ENA Respiratory to embed smart study design using simulation-guided clinical trial design platform, KerusCloud

Aiden and Katie in action at the PSI Conference 2023

In June, an Exploristics team comprised of Aiden Flynn, Kim Hacquoil, Sam Matthews, Andrew Mills and Katie Taiyari were delighted to attend the annual PSI Conference 2023 in Hammersmith.

KerusCloud2023 launch

We are pleased to announce the global launch of the KerusCloud Spring 2023 release, Exploristics’ ground-breaking clinical trial design platform.

Exploristics is delighted to be participating in Belfast City Council’s new inclusive growth initiative, the Belfast Business Promise.

Innovate UK logo

Exploristics has completed an Innovate UK award supporting further R&D for KerusCloud.

The Effective Statistician

Exploristics are pleased to be participating in the first Effective Statistician Conference which will take place on April 25th, 2023

KerusCloud Spring 2022 Release

We are pleased to announce the global launch of the KerusCloud Spring 2022 release, Exploristics’ ground-breaking clinical trial design platform.

Exploristics awarded Silver Diversity Charter Mark

We are proud to announce that Exploristics has attained the Silver Diversity Charter Mark.

clarivate

Integration of Clarivate Cortellis data with cloud-based simulation platform, KerusCloud, for smarter, more efficient study design 

Collaboration with the Francis Crick Institute and UCL on the COVASE trial

Exploristics is delighted that its work on the COVASE trial with the Crick, UCH and Target to Treatment has won the 2021 Sir David Cooksey prize

renovion

Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform KerusCloud

innovate-uk

Innovate UK grants Smart Award to expand KerusCloud.

Susan-Clement-Davies

Exploristics is delighted to welcome Susan Clement-Davies to the Board as a Non-Executive Director. Susan is an experienced life sciences financier

Aiden Flynn

We are delighted to announce that Exploristics’ CEO, Dr Aiden Flynn, has been appointed Commercial Director on the Board of Directors at PSI.

Istesso

Exploristics is pleased to announce a new collaboration agreement with Istesso to embed study simulation using innovative software platform KerusCloud.

KC2021-news

We are pleased to announce the global launch of the KerusCloud Spring 2021 release, Exploristics’ ground-breaking clinical trial design platform.

WISE

Exploristics have joined the WISE Campaign, and are delighted to be part of the journey promoting STEM, equality, diversity and inclusion.

galapagos

Exploristics signs collaboration agreement with Galapagos to embed study simulation into clinical development with innovative software platform KerusCloud.

Wise

We’re delighted to have been awarded membership of the NIWISE hub.

ukri

Exploristics joins the Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT).

exploristics platinum innovator award

Exploristics has been recognised as a Platinum Level Innovator by Innovate NI.

exploristics spencer health solutions

Exploristics’ CEO discusses how data simulation studies can reduce the risk and costs of clinical trials.

Collaboration with the Francis Crick Institute and UCL on the COVASE trial

Exploristics is pleased to announce its involvement with the COVASE trial evaluating cystic fibrosis drug, Dornase alfa, as a treatment for COVID-19.

UK BioIndustry Association

Exploristics is pleased to have become a member of the UK BioIndustry Association.

exploristics KerusCloud update launch

We are hosting an initial series of webinars following the global launch of KerusCloud 2.

exploristics KerusCloud update launch

We are pleased to announce the global launch of the next generation of the ground-breaking KerusCloud 2.

exploristics diversity mark 1

Exploristics receives Bronze Diversity Charter Mark

exploristics avicenna alliance

Exploristics is pleased announce that we have joined the Avicenna Alliance.

innovate-uk

Exploristics has won a prestigious Innovate UK Smart award for £340K.

exploristics pharma industry awards

Exploristics nominated for the Innovation of the Year award at the Irish Pharma Industry Awards 2019.

exploristics diversity mark

Exploristics has been awarded the Bronze Diversity Mark Charter Mark.

exploristics celebrate 10 years business

Exploristics is celebrating its ten year anniversary!

Chris Molloy exploristics new non-executive

Two new announcements this week from Exploristics.